Private Equity-Venture Capital (PE-VC) investments dropped 32 per cent year-on-year in terms of value in April 2026 at $1.9 billion as against $2.8 billion in the same month last year, as per data from research firm Venture Intelligence.
The volume of deals also saw a similar decline down 30 per cent from 124 deals in April 2025 to 87 in April 2026. Sequentially, the value of deals nearly halved this month from the $4.7 billion in investments across 120 deals in March 2026.
Overall, PE-VC investments in the first four months of 2026 stood at around $12 across 435 deals as against $14.6 billion across 467 deals in the same period last year.
The value of mega deals (over $100 million) also went down $1.1 billion invested in six such deals as against $1.9 billion across seven deals in April 2025.
The largest deal in the month was the $280 million that digital lending firm Kreditbee raised from Motilal Oswal Alternates, Advent International and PremjiInvest, among others.. Apothecon Pharmaceuticals’ $270 million raise from Everstone , and hospital chain Baby Memorial Hospital’s raising $186 million from KKR were other major deals.
Investments in early-stage companies went down to $253 million across 40 deals while growth stage investments stood flat at $520 million across 26 deals. Late stage investments also went down sharply to $376 million from $653 million.
The average early stage deal size doubled to $6 million as against $3 million in April 2025. For growth stage it went up to $20 million($12 million) and late stage saw a drop to $25million ($33 million).
Published on May 1, 2026
